Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Five Major Univ. & Hospital Trauma Centers to Use QuikClot(R) Combat Gauze(TM) in Clinical Trials

Abstract:
Z-Medica Corporation (Z-Medica), a medical products company focused on innovative hemostatic nano-technologies, today announced that it has been awarded a $2.9 million contract from the United States Navy and Marine Corps to fund large-scale human studies on stopping bleeding in penetrating wounds, using the company's new QuikClot(R) Combat Gauze(TM). The U.S. Department of Defense Committee on Tactical Combat Casualty Care recently selected QuikClot(R) Combat Gauze(TM) as the firstline hemorrhage treatment for tourniquet-resistant wounds for all branches of the U.S. military.

Five Major Univ. & Hospital Trauma Centers to Use QuikClot(R) Combat Gauze(TM) in Clinical Trials

WALLINGFORD, CT | Posted on September 24th, 2008

The clinical studies will take place at five major university and hospital trauma centers: Johns Hopkins University in Baltimore; the University of Miami; the University of Massachusetts Medical School in Worcester, Mass.; Vanderbilt University in Nashville; and Hartford Hospital in Hartford, Conn. Specifically, the study will address small entry/large exit wounds from high velocity bullets, traumatic injuries frequently encountered on the battlefield.

'We are proud to support the U.S. Navy and Marine Corps in their medical mission and are gratified that they selected the best available hemostatic agent for these important studies that will result in new knowledge and medical techniques for saving both military and civilian lives,' said Z-Medica CEO Raymond J. Huey.

QuikClot(R) Combat Gauze(TM) combines surgical gauze with a proprietary inorganic material that stops arterial and venous bleeding in seconds. The material, pliable and familiar to medical personnel, can be fitted to any size or shape wound -- including penetrating wounds. It is easily removed once the bleeding stops. The product comes in rolls four yards long by three inches wide.

Prior to its deployment earlier this year, QuikClot(R) Combat Gauze(TM) was tested in pre-clinical trials at the Naval Medical Research Center, the University of California, Santa Barbara, the University of Massachusetts Medical School and at various field facilities. It has 510(k) clearance from the U.S. Food & Drug Administration.

In addition to QuikClot(R) Combat Gauze(TM), Z-Medica manufacturers and markets QuikClot(R) brand hemostatic agent and QuikClot(R) ACS+(TM) for military use, QuikClot(R) 1st Response(TM) for first responders and a suite of consumer first aid products including QuikClot(R) NoseBleed(TM), the first to be based on the new hemostatic gauze technology. More than one million units of QuikClot(R) are deployed in the U.S. and 36 countries worldwide.

####

About Z-Medica Corporation (Z-Medica)
Z-Medica Corporation headquarters is located at 4 Fairfield Blvd., Wallingford, Connecticut 06492. For more information, please call (203) 294-0000.

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iran to Hold 3rd Int'l Engineering Materials, Metallurgy Conference October 25th, 2014

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014

Nanomedicine

NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014

Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Announcements

Iran to Hold 3rd Int'l Engineering Materials, Metallurgy Conference October 25th, 2014

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Military

NanoTechnology for Defense (NT4D) October 22nd, 2014

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

Imaging electric charge propagating along microbial nanowires October 20th, 2014

1980s aircraft helps quantum technology take flight October 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE